G9205 – Patient starting antiviral treatmentfor hepatitis c during the measurement period
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9205
- Long description
- Patient starting antiviral treatmentfor hepatitis c during the measurement period
- Short description
- Hep c antiviral started
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
M5BSpecialist - psychiatry- Added
- January 1, 2014
- Last change
- January 1, 2017 – No change
- Termination date
- December 31, 2016
Frequently asked questions
What is HCPCS code G9205?
G9205 is a HCPCS Level II code for patient starting antiviral treatmentfor hepatitis c during the measurement period. It was discontinued on December 31, 2016.
Does Medicare cover G9205?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9197 – Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis
- G9198 – Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
- G9199 – Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))
- G9200 – Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
- G9201 – Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
- G9202 – Patients with a positive hepatitis c antibody test
- G9203 – Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
- G9204 – Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
- G9206 – Patient starting antiviral treatment for hepatitis c during the measurement period
- G9207 – Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
- G9208 – Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
- G9209 – Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
- G9210 – Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
- G9211 – Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
- G9212 – Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
- G9213 – Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.